A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase - Wikidata - awgldk - TriplyDB

A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase

A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase

http://www.wikidata.org/entity/Q28343191

about

In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract Phenylketonuria: a review of current and future treatments Microbial enzymes: industrial progress in 21st century New Strategies for the Treatment of Phenylketonuria (PKU)Discovery of Two Cyanobacterial Phenylalanine Ammonia Lyases: Kinetic and Structural Characterization † , ‡Structural and Biochemical Characterization of the Therapeutic Anabaena variabilis Phenylalanine Ammonia Lyase Biodegradation of aromatic compounds by Escherichia coli Artificial cell bioencapsulation in macro, micro, nano, and molecular dimensions: keynote lecture Phenylketonuria: old disease, new approach to treatment.Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU Recombinant proteins for genetic disease.Phenylalanine hydroxylase deficiency.Genetic and genomic systems to study methylmalonic acidemia.Phenylketonuria: an inborn error of phenylalanine metabolism.Artificial cells for replacement of metabolic organ functions.Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.Up to date knowledge on different treatment strategies for phenylketonuria.State-of-the-art 2003 on PKU gene therapy.Artificial cells for cell and organ replacements.Therapeutic applications of polymeric artificial cells.Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria Gene therapy for disorders affecting children, progress and potential.Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria Progress toward cell-directed therapy for phenylketonuria.The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria.Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria.Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.Antioxidant treatment strategies for hyperphenylalaninemia.Biotechnological production and applications of microbial phenylalanine ammonia lyase: a recent review.Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.Clinical therapeutics for phenylketonuria.Recombinant l-phenylalanine ammonia lyase from Rhodosporidium toruloides as a potential anticancer agent.Mannose 6-phosphate conjugation is not sufficient to allow induction of immune tolerance to phenylalanine ammonia-lyase in dogs.Biochemical Evaluation of Phenylalanine Ammonia Lyase from Endemic Plant Cyathobasis fruticulosa (Bunge) Aellen. for the Dietary Treatment of Phenylketonuria.Study on a novel strategy to treatment of phenylketonuria.Biopterin responsive phenylalanine hydroxylase deficiency.Structural basis for the entrance into the phenylpropanoid metabolism catalyzed by phenylalanine ammonia-lyase.Phenylketonuria: A new look at an old topic, advances in laboratory diagnosis, and therapeutic strategies.Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening.Descriptive and hedonic analyses of low-Phe food formulations containing corn (Zea mays) seedling roots: toward development of a dietary supplement for individuals with phenylketonuria.

P2860

Q24627253-7460C489-219E-4681-8454-977C7C259079 Q26770291-28D9A73D-2518-4357-A4B8-B76DCE6B73DB Q26970832-A26B9555-1E88-483B-B2E7-E5C700A53459 Q26999278-9493F876-85A5-4795-909C-63F04602FE87 Q27641281-238AB9D8-A7A6-48BF-A9A2-F27B3DC2FCBD Q27650847-CCB8FB70-CC25-48D7-8AFB-79BC0D08323B Q28208239-41105F45-E90D-4219-B65D-B7F5B4E34805 Q28251032-5471B27F-F6B4-45BE-B4EF-E4A1959AAEBD Q33537485-6C20E4F6-BCE2-40CB-A800-39C292EF45C5 Q33698843-7118FAB4-DF35-4807-8D45-F3AE1BEAAE16 Q33713530-1FE06810-861B-45ED-AABD-8484E202CC66 Q34183829-3EE8AF14-C59A-4048-BFF3-2DE64DF24794 Q34453620-431FED91-3080-430D-B320-D04B09DA003E Q34787712-80E7F669-422D-4579-A1A5-7C6DDA174827 Q35129286-EFFD7343-694B-4CE2-9600-A280E3D205ED Q35490408-D739B0A9-A105-4F5D-AC72-58E4D40C5535 Q35623929-5EB2629A-2375-44AC-BA1F-1FC92804B3AB Q35631781-6A3B55FA-998B-458E-904F-82B47E8B5168 Q35717682-664474A4-3C7B-488B-8E3B-060E1703294A Q36058455-776D812C-3AC2-4574-AB1E-814EC04AB96D Q36304253-29D78D98-5C6D-4FBF-9247-739F5E46B457 Q36816069-2AD898F2-7961-4B26-A4B9-B582F7780628 Q37081629-AA27B633-AE30-4A13-87DE-CE8EA2706315 Q37170974-092182F0-D643-49B1-82E9-C0A117556596 Q37221639-CB15A634-9976-406E-AFFB-CDF229B50348 Q37480507-14410922-80DA-4E04-8E9C-894F11F23907 Q38096351-6CF0D045-4A36-4862-AB53-1B1D86A9F16E Q38105266-5BFF6325-E6F2-45DF-BDC9-2D5EF5A1208C Q38107989-C9E52A24-D1AE-4131-BB5B-BD080CAA0514 Q38159436-7C2D898A-78A5-4EDD-84BC-7790B8405C4A Q38383086-EA5F2365-8EC8-478D-8A07-1B1061F6FF61 Q39146109-69D80D5C-7FD7-48ED-81A5-E2298FDDECFE Q42257752-B65152A0-8C49-4227-A704-E0F26D61BD61 Q42354366-436A5E21-DB1E-4432-AECA-F87A855B3F7D Q44134678-0E21B332-C604-40A2-9C0A-9F2A7E887E8E Q44730873-316B71CB-78A8-4D2D-93E9-9374E1387FD9 Q45153599-95C80F34-4986-423F-87F4-51485A0EFCA9 Q45874121-B5D1C791-1E93-4F82-9612-1CFFB18D7474 Q46866313-BAFCDC6F-CEEC-4352-80CC-2F2F26FDE119 Q50218729-CB8155B9-3D72-4EEC-AA8A-FBF740B64A18

P2860

A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase

http://www.wikidata.org/entity/Q28343191

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

A different approach to treatm ...... nt phenylalanine ammonia lyase

@ast

A different approach to treatm ...... nt phenylalanine ammonia lyase

@en

A different approach to treatm ...... nt phenylalanine ammonia lyase

@nl

type

label

A different approach to treatm ...... nt phenylalanine ammonia lyase

@ast

A different approach to treatm ...... nt phenylalanine ammonia lyase

@en

A different approach to treatm ...... nt phenylalanine ammonia lyase

@nl

prefLabel

A different approach to treatm ...... nt phenylalanine ammonia lyase

@ast

A different approach to treatm ...... nt phenylalanine ammonia lyase

@en

A different approach to treatm ...... nt phenylalanine ammonia lyase

@nl

P1433

Q28343191-10AA22A9-1A70-4167-955B-DC41CE70AB8C

P1476

Q28343191-4A5C6DB2-9048-4AEE-BA9D-AA2995CB9D8E

P2093

Q28343191-6879800A-B4A8-4979-896A-4D6427A29FDA

Q28343191-7AB95A00-7637-40BF-9D1D-C93F604D8C92

Q28343191-92AA7E43-7C62-4C96-9ECC-B6FD0BECB9EC

Q28343191-98B1F75A-6B15-41F7-B560-F34AB1F31088

Q28343191-A1E64946-C39A-4430-A9BA-8FD79920BD58

Q28343191-AEF440FA-846B-4486-A5C5-49EAE7D98555

Q28343191-F3DC6936-2841-41E4-8281-06A46BBBD789

Q28343191-FE481535-AC0D-4865-8F31-979449AA9BB5

P2860

Q28343191-0255D097-772E-467E-BB1F-991FF92D6984

Q28343191-10457491-FA5B-4F53-BDF4-8767EB155234

Q28343191-42035C4E-B03D-4F82-80EA-B67350428B5B

Q28343191-682697F9-A049-46BD-8FE8-8F57AD559F93

Q28343191-69A21DEB-D3E9-4D31-89FC-14B27A699D5F

Q28343191-7FBA4563-8985-44C1-BB73-B3EB34629AEA

Q28343191-8AEE0915-2F7D-477C-9AB9-AAC84989B1B4

Q28343191-9434CC68-DB7A-4410-99C8-8FB57F58BEAA

Q28343191-94611276-25FA-4A2E-B5A0-D43BDA8C3180

Q28343191-98D84C55-BC5C-4D8F-82FE-3DB1F438F02E

P304

Q28343191-99BADA71-0382-433A-9C15-FEA85BF02996

P31

Q28343191-FB459EA1-EC9A-43A9-8A99-231DAF9CB9D7

P3181

Q28343191-95B40086-ED85-4F6A-9DCF-77890EBEB9E0

P356

Q28343191-EF65BA89-8D1E-4641-83C5-A7C6A1452340

P407

Q28343191-C1B9A951-C4F9-4B4A-85B2-471619DDDF65

P433

Q28343191-D1137814-0CF0-4342-999F-5E199C63F4D0

P478

Q28343191-B23536EC-165E-486D-AE7B-1D061087A6F9

P577

Q28343191-36317394-B19F-4DAB-9E49-EFD675EA4C0F

P5875

Q28343191-F81888EC-BE29-4507-AAA7-E26C606B7845

P698

Q28343191-633858B4-EB83-40FC-8D60-BDBD2312ACA9

P921

Q28343191-2F00AD05-8BA9-4642-B4CF-BB145B99FCDE

P932

Q28343191-EAA20695-4774-4667-815D-30DCD3808A97

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A different approach to treatm ...... nt phenylalanine ammonia lyase

@en

P2093

C N Sarkissian

http://www.w3.org/2001/XMLSchema#string

C R Scriver

http://www.w3.org/2001/XMLSchema#string

F Blain

http://www.w3.org/2001/XMLSchema#string

H Su

http://www.w3.org/2001/XMLSchema#string

R Heft

http://www.w3.org/2001/XMLSchema#string

R Peevers

http://www.w3.org/2001/XMLSchema#string

T M Chang

http://www.w3.org/2001/XMLSchema#string

Z Shao

http://www.w3.org/2001/XMLSchema#string

P2860

Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase

Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction

Mouse models of human phenylketonuria.

Yeast phenylalanine ammonia-lyase. Purification, properties, and the identification of catalytically essential dehydroalanine.

Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum

Fc epsilon R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian aborigines.

Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria.

Molecular cloning of the phenylalanine ammonia lyase gene from Rhodosporidium toruloides in Escherichia coli K-12

Mutants: consumers with special needs.

Interorgan amino acid nutrition.

P304

2339-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3978425

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.96.5.2339

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13237991

http://www.w3.org/2001/XMLSchema#string

P698

10051643

http://www.w3.org/2001/XMLSchema#string

P921

phenylketonuria

P932

26785

http://www.w3.org/2001/XMLSchema#string